Targeted therapies: Using β-blockers to inhibit breast cancer progression
- PMID: 21808268
- DOI: 10.1038/nrclinonc.2011.123
Targeted therapies: Using β-blockers to inhibit breast cancer progression
Abstract
Three recent population studies have translated laboratory investigations into a clinical setting and concur in presenting evidence that suggest a dramatic new role for β-blockers in reducing metastases, tumor recurrence and specific mortality in breast cancer. Should we be skeptical about these controversial findings?
Comment on
-
Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer.J Clin Oncol. 2011 Jul 1;29(19):2645-52. doi: 10.1200/JCO.2010.33.4441. Epub 2011 May 31. J Clin Oncol. 2011. PMID: 21632501 Free PMC article.
-
Beta blockers and breast cancer mortality: a population- based study.J Clin Oncol. 2011 Jul 1;29(19):2635-44. doi: 10.1200/JCO.2010.33.5422. Epub 2011 May 31. J Clin Oncol. 2011. PMID: 21632503
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
